CN103585463B - Drug for treating peripheral facial paralysis - Google Patents
Drug for treating peripheral facial paralysis Download PDFInfo
- Publication number
- CN103585463B CN103585463B CN201310572378.4A CN201310572378A CN103585463B CN 103585463 B CN103585463 B CN 103585463B CN 201310572378 A CN201310572378 A CN 201310572378A CN 103585463 B CN103585463 B CN 103585463B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- drug
- facial paralysis
- peripheral facial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating peripheral facial paralysis. The drug comprises the components in parts by weight as follows: 8 parts of herba chloranthi serrati, 6 parts of iresine herbstii, 3 parts of saussurea graminea, 5 parts of passiflora flowers, 3 parts of fraxinus malacophylla, 6 parts of laportea cuspidata(Wedd.)FriisSceptro, 3 parts of ficus formosana Maxim.var.shi-madai(Hayata)W.C.Cheng, 2 parts of herba cissampelotis, 2 parts of coelmactra antiquate, 5 parts of lysimachia barystachys Bunge, 6 parts of filipendula palmata, 3 parts of orchis and 3 parts of herba haleniae. All the components of the drug are natural materials, and the drug is good in safety, explicit in curative effect and suitable for being widely popularized clinically.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of peripheral facial paralysis.
Background technology
Peripheral facial paralysis refers to idiopathic facial palsy, also known as Bell's palsy, refers to one-sided infranuclear facial palsy that is agnogenio, acute onset.It is commonly encountered diseases.Any age all can fall ill, and male is slightly many.Usual Acute onset, reaches peak within a few hours or 1 ~ 2 day.Sick just can have pain after angle of mandible or ear.Cardinal symptom is side facial expression myoparalysis.Volume stricture of vagina disappears, and can not frown, palpebral fissure dysraphism, and when examination is closed one's eyes, paralysis branch hole ball upwards foreign side rotates, and exposes white sclera, claims bell's phenomenon.Sick side nasolabial fold shoals, ptosis of labial angle, askew to strong side time grinningly, air-blowing or gas leakage when whistling because of orbicularis oris paralysis, and because buccinator muscle paralysis, food is easily stranded between the tooth cheek of disease side.Pathological changes, when tympanic cord scope of participants nerve place is above, can have homonymy gustatory anesthesia.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of peripheral facial paralysis.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of peripheral facial paralysis, it is made up of the material of following weight proportioning: Chloranthus japonicusSieb. 8 parts, Herba Iresines Herbstii 6 parts, Herba Saussureae gramineae 3 parts, Herba Passiflorae Caeruleae 5 parts, Cortex Fraxini Malacophyllae Radicis 3 parts, Radix Laporteae Macrostachyae 6 parts, Radix Fici Angustipoliae 3 parts, Herba Cissampelotis pareiae 2 parts, Mactraantiquata Spengler 2 parts, XUEJINGCAO 5 parts, Filipendula palmata 6 parts, Herba Orchidis Latifoliae 3 parts and Herba Haleniae Corniculatae 3 parts.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of peripheral facial paralysis of the present invention are all natural materials, and safety is better, and clear curative effect, is suitable for large-scale promotion clinically.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take Chloranthus japonicusSieb. 8 grams, Herba Iresines Herbstii 6 grams, Herba Saussureae gramineae 3 grams, Herba Passiflorae Caeruleae 5 grams, Cortex Fraxini Malacophyllae Radicis 3 grams, Radix Laporteae Macrostachyae 6 grams, Radix Fici Angustipoliae 3 grams, Herba Cissampelotis pareiae 2 grams, Mactraantiquata Spengler 2 grams, XUEJINGCAO 5 grams, Filipendula palmata 6 grams, Herba Orchidis Latifoliae 3 grams and Herba Haleniae Corniculatae 3 grams, add 6000 milliliters, water, heat 4 hours at 80 DEG C in the flask that condensing tube is housed, filter, filtrate is decoction of the present invention.
Experimental example
Diagnostic criteria
Reference " neurological " (Wang Weizhi. neurological [M]. Beijing: People's Health Publisher, 2005:90.) work out: (1) onset is hurried, have before sick more and suffer from cold, dry or pharyngitis history, small number of patients after disease a few days ago can have ear, the advanced symptoms such as in ear pain or facial discomfort; (2) side facial muscle paralysis and numbness facial hemiparalysis, palpebral fissure increases, and hypophasis maybe can not close, and volume stricture of vagina and nasolabial fold shoal or disappear, whole volume, frown, show tooth, drum cheek obstacle, gargle leak, food remains between tooth cheek when having meal; (3) can there is 2/3 hypogeusia or disappearance hyperacusis before tongue in part Ipsilateral, and ear's herpes can appear in minority.Get rid of the disease that cerebrovas-cularaccident, otitis media, tumor, meningitis, surgical injury, Guillain Barre etc. cause facial paralysis.
Choose patient 80 example meeting above-mentioned standard, wherein man 40 example, female 40 example; 25 ~ 45 years old age, average 32 years old.
Use the decoction of preparation in embodiment 1 to treat, every day 1 time, oral 100 milliliters at every turn, treating 7 days is a course for the treatment of.
Criterion of therapeutical effect
Reference " tcm internal medicine disease treatment is conventional " criterion of therapeutical effect (red legend cutting edge of a knife or a sword. national standard application tcm internal medicine disease treatment routine [M]. Changsha: Hunan science tech publishing house, 1993:266.) formulate.Recovery from illness: symptom disappears completely, mouth eye is rectified, and nasolabial fold is symmetrical, and recoveries such as frowning, close order, rouse the cheek grinningly, pout one's lips is normal; Take a turn for the better: symptom and sign improves, but leaves over facial muscle dysfunction in various degree, and as outward appearance face has slightly asymmetric, catacleisis is not good enough, during laugh, bicker is slightly crooked etc.; Invalid: symptom, sign are without improvement.
Through the treatment of a course for the treatment of, find that the symptom of all patients disappears completely, mouth eye is rectified, nasolabial fold is symmetrical, recoveries such as frowning, close order, rouse the cheek grinningly, pout one's lips is normal, all meets the standard of recovery from illness, and does not observe obvious untoward reaction at whole treatments period.
Claims (1)
1. treat the medicament of peripheral facial paralysis for one kind, it is characterized in that, it is made up of the material of following weight proportioning: Chloranthus japonicusSieb. 8 parts, Herba Iresines Herbstii 6 parts, Herba Saussureae gramineae 3 parts, Herba Passiflorae Caeruleae 5 parts, Cortex Fraxini Malacophyllae Radicis 3 parts, Radix Laporteae Macrostachyae 6 parts, Radix Fici Angustipoliae 3 parts, Herba Cissampelotis pareiae 2 parts, Mactraantiquata Spengler 2 parts, XUEJINGCAO 5 parts, Filipendula palmata 6 parts, Herba Orchidis Latifoliae 3 parts and Herba Haleniae Corniculatae 3 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310572378.4A CN103585463B (en) | 2013-11-15 | 2013-11-15 | Drug for treating peripheral facial paralysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310572378.4A CN103585463B (en) | 2013-11-15 | 2013-11-15 | Drug for treating peripheral facial paralysis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103585463A CN103585463A (en) | 2014-02-19 |
| CN103585463B true CN103585463B (en) | 2015-04-29 |
Family
ID=50075916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310572378.4A Expired - Fee Related CN103585463B (en) | 2013-11-15 | 2013-11-15 | Drug for treating peripheral facial paralysis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103585463B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579852A (en) * | 2012-03-22 | 2012-07-18 | 张霞 | Medicament for treating peripherical facial paralysis |
| CN103142978A (en) * | 2013-03-22 | 2013-06-12 | 邓广博 | Medicine for treating peripheral facial paralysis |
-
2013
- 2013-11-15 CN CN201310572378.4A patent/CN103585463B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579852A (en) * | 2012-03-22 | 2012-07-18 | 张霞 | Medicament for treating peripherical facial paralysis |
| CN103142978A (en) * | 2013-03-22 | 2013-06-12 | 邓广博 | Medicine for treating peripheral facial paralysis |
Non-Patent Citations (2)
| Title |
|---|
| 周围性面瘫后遗症的中医治疗体会;贾慧彦;《求医问药》;20121231;第10卷(第1期);79 * |
| 自拟方治疗面瘫的临床观察;刘素英;《中外医疗》;20121231(第7期);109 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103585463A (en) | 2014-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102657785B (en) | Medicinal composition for treating gingivitis | |
| CN102579852B (en) | Medicament for treating peripherical facial paralysis | |
| CN103585463B (en) | Drug for treating peripheral facial paralysis | |
| CN104398670B (en) | By clearing lung-heat heat except the Chinese medicine preparation of lung poison treatment alopecia seborrheica | |
| CN103142978A (en) | Medicine for treating peripheral facial paralysis | |
| CN102805800A (en) | Traditional Chinese medicine composition for treating neurodermatitis | |
| CN103142983B (en) | Medicament for treating chronic pharyngitis | |
| CN101632775B (en) | Externally-applied traditional Chinese medicine ointment | |
| CN103893530A (en) | Traditional Chinese medicine for treating otitis externa | |
| CN100515467C (en) | Traditional Chinese medicine for treating epilepsy | |
| CN104147219B (en) | Chinese medicine composition of a kind of pain relieving relieving fainting and preparation method thereof | |
| CN104825809A (en) | Medicament for treating peripheral facial paralysis | |
| CN103110749B (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN105079387A (en) | Traditional Chinese medicine for treating prosopoplegia | |
| CN107970381A (en) | A kind of Xuancheng's pawpaw tea of resolving sputum and its preparation method and application | |
| CN109549886A (en) | A kind of preparation method of anti-inflammation gargle water | |
| CN101229277A (en) | Medicine compounds for treating leukemia | |
| CN105616580A (en) | Drug for treating facioplegia | |
| CN114209638A (en) | Compound broadleaf holly leaf traditional Chinese medicine composition for preparing toothpaste and compound broadleaf holly leaf traditional Chinese medicine toothpaste | |
| CN104491276A (en) | Traditional Chinese medicine preparation for treating tinnitus and preparation method thereof | |
| CN104288306A (en) | Traditional Chinese medicine eye drop for treating ocular diseases and preparation method thereof | |
| CN104107350A (en) | Traditional Chinese medicinal preparation for treating nervous headaches | |
| CN104706936A (en) | Traditional Chinese medicine for treating otitis externa | |
| CN103735911B (en) | A kind of medicine and preparation method who treats rubella | |
| CN103463444A (en) | Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150429 Termination date: 20151115 |
|
| EXPY | Termination of patent right or utility model |